During the past decade, Vivantes Netzwerk für Gesundheit GmbH conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 10 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vivantes Netzwerk für Gesundheit GmbH" #1 sponsor was "Boehringer Ingelheim" with 11 trials, followed by "Biotronik AG" with 2 trials sponsored, "Biotronik SE & Co. KG" with 1 trials sponsored, "Cardionovum GmbH" with 1 trials sponsored and "Heidelberg University" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vivantes Netzwerk für Gesundheit GmbH" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "CliPS Service" with 1 trials as a collaborator, "H. Lundbeck A/S" with 1 trials as a collaborator, "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator and "Medstar Health Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Vivantes Netzwerk für Gesundheit GmbH" are "Atrial Fibrillation" (3 trials), "Heart Failure" (3 trials), "Stroke" (2 trials), "Aortic Valve Stenosis" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Vivantes Netzwerk für Gesundheit GmbH" in a lesser frequency.

Most popular intervention types in "Vivantes Netzwerk für Gesundheit GmbH" are "Drug" (13 trials), "Device" (5 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (3 trials), "Placebo" (3 trials), "Dabigatran Etexilate 150mg" (2 trials), "Warfarin" (2 trials) and "APERTO OTW DCB" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vivantes Netzwerk für Gesundheit GmbH" are 21 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Vivantes Netzwerk für Gesundheit GmbH". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Vivantes Netzwerk für Gesundheit GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Vivantes Netzwerk für Gesundheit GmbH, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".

Vivantes Netzwerk für Gesundheit GmbH has several departments that took part in Clinical trials: "Vivantes Neukölln Neurologie" - 4 trials, "Klinik Fur Innere Medizin Hamatologie and Onkologie" - 4 trials, "Vivantes Klinikum am Urban, Klinik für Urologie" - 3 trials, "Vivantes Klinikum Am Urban Klinik für Innere Medizin Hämatologie und Onkologie" - 2 trials, "Klinische und interventionelle Neuroradiologie Vivantes Klinikum Neukölln" - 2 trials, "Vivantes Auguste Viktoria Klinikum Neurologie" - 2 trials, "Vivantes Klinikum Neukölln - Dep. of Anesthesiology, Intensive Care Medicine and Pain Therapy" - 2 trials, "Vivantes Humboldt Klinikum, Klinik für Innere Medizin, Kardiologie und konservative Intensivmedizin" - 2 trials